Would you like more details? Our expert-led virtual demonstrations will give you additional insights you can bring back to your organization.
Rapid and accurate testing on a massive scale is vital to address the challenges of the COVID-19 pandemic.
Siemens Healthineers continues to deliver high-value COVID-19 care across disciplines throughout the patient care pathway.
As society continues to navigate through the COVID-19 pandemic, there is a critical public health need to get ahead of the spread with a fast and simple test for all.
* These SARS-CoV-2 molecular and serology tests have not been FDA cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories. The molecular test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The serology test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary from country to country and is subject to varying regulatory requirements.
** Not available for sale in the U.S. Product availability may vary by country.